Drug Drotaverin: instructions for use

"Drotaverin" instructions for use refers to the pharmacological group of antispasmodics. The main active substance in this preparation is drotaverin, and the drug itself is manufactured in such dosage forms as usual tablets, capsules for internal administration and solution for injection.

This myotropic antispasmodic has such pharmacological and chemical parameters that are close to the properties of "Papaverin". But in terms of the degree of action and its duration, the properties of "Drotaverina" are much stronger than those of "Papaverin." The drug has the ability to reduce the flow of elements of Ca2 + into cells. "Drotaverine" instruction describes how a drug that helps improve overall intestinal motility, helps to dilate blood vessels. The medicine does not have any negative effect on the vegetative system and does not have the ability to touch the CNS.

Having spasmolytic effect, the drug "Drotaverin" is effective for use in cases where there are contraindications for the use of drugs from the group of m-holinoblokatorov. As a rule, these drugs are used by patients for the treatment of glaucoma and prostatic hypertrophy. When taking the drug by intravenous administration, its components begin to act after about two to four hours, with the greatest effect the drug begins to have in half an hour.

This drug is prescribed for the prevention and treatment of diseases such as muscle spasms, colic in the kidneys, intestines or gall bladder, cholecystitis. The drug is effective in treating spastic constipation, colitis, gastroduodenitis, ulcers of the duodenum and stomach.

"Drotaverine" is used in the therapy of endarteritis, cerebral arteries. The instruction also indicates the possibility of using the drug to overcome a number of gynecological problems, in particular, to prevent miscarriages and postnatal fights.

It should be borne in mind that when taking the drug "Drotaverin", the instruction provides and warns about contraindications, in which the use of this drug should be excluded or limited. First, it should not be taken if the patient is diagnosed with severe forms of hepatic and renal insufficiency, cardiogenic shock, glaucoma in a closed-angle form. Secondly, the drug is not prescribed in cases of pregnancy and breastfeeding. Finally, Drotaverin, a compound that includes methylene derivatives in the form of a hydrochloride, can cause serious problems in those patients who have hypersensitivity to these compounds.

In addition, when taking the drug may experience side effects in the form of dizziness, rapid heartbeat, the emergence of a number of allergic reactions. Particular care should be taken to use the drug by intravenous administration. At such reception there can come a collapse, cardiac blockades and stops of the respiratory center.

When an overdose occurs in patients, cardiac activity is dramatically reduced, and this can lead to its arrest or paralysis of the respiratory center.

"Drotaverin", the instruction recommends to use in strictly specified in it doses and modes of reception. Before any use of this medication, a doctor's consultation is mandatory.

If the drug is prescribed as part of complex therapy, it should be borne in mind that it can enhance the effect of "Papaverin", but blood pressure will decrease with simultaneous admission with tricyclic antidepressants. Spasmolytic properties of the drug are increased by the simultaneous use of phenobarbital.